93 132
Pill imprint 93 132 has been identified as Lamotrigine (chewable, dispersible) 25 mg.
Lamotrigine is used in the treatment of bipolar disorder; seizure prevention; schizoaffective disorder; depression; anxiety (and more), and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy.
Lamotrigine 25 mg is not subject to the Controlled Substances Act.
See also related documents.
Lamotrigine (chewable, dispersible) Images
- Imprint:
-
93
132 - Strength:
- 25 mg
- Color:
- White
- Size:
- 8.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide
croscarmellose sodium
mannitol
microcrystalline cellulose
corn starch
saccharin sodium
sodium starch glycolate type A potato
sodium stearyl fumarate
- Drug Class:
- Triazine anticonvulsants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- 00093-0132
Advertisement
More Lamotrigine (Chewable, Dispersible) resources
- Lamotrigine (Wolters Kluwer)
- Lamotrigine Chewable Dispersible Tablets (Wolters Kluwer)
- Lamotrigine Extended-Release Tablets (Wolters Kluwer)
- Lamotrigine Orally Disintegrating Tablets (Wolters Kluwer)
- lamotrigine (Cerner Multum)
- lamotrigine (Micromedex) - Includes Dosage Information
- Lamotrigine (AHFS DI)
- Lamotrigine (FDA)
- Lamotrigine Tablets (FDA)
- Lamotrigine (Wolters Kluwer)
Search Again
